1 – 13 of 13
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
(
- Contribution to journal › Article
- 2022
-
Mark
Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture-prone atherosclerotic plaques
(
- Contribution to journal › Article
- 2021
-
Mark
Elevated circulating follistatin associates with an increased risk of type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Technological readiness and implementation of genomic-driven precision medicine for complex diseases
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events
(
- Contribution to journal › Article
-
Mark
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals
(
- Contribution to journal › Article
- 2019
-
Mark
High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke
(
- Contribution to journal › Article
-
Mark
Phenotypic and genotypic differences between Indian and Scandinavian women with gestational diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Soluble TRAIL-R2 a marker of plaque cell apoptosis and cardiovascular events.
(
- Contribution to journal › Article
- 2018
-
Mark
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
(
- Contribution to journal › Article
- 2017
-
Mark
A low-frequency inactivating AKT2 variant enriched in the finnish population is associated with fasting insulin levels and type 2 diabetes risk
(
- Contribution to journal › Article
-
Mark
Data Descriptor: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
(
- Contribution to journal › Article
- 2016
-
Mark
Glucose-Dependent Insulinotropic Polypeptide (GIP) Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.
(
- Contribution to journal › Article